Covered recipient · General Payments record
SHEILA F FRIEDLANDER
Allopathic & Osteopathic Physicians Dermatology Pediatric Dermatology
General Payments · PY2018–2024
$12,733.43
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.40 | 8 |
| Education | $168.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $123.17 | 2 |
| LEO Pharma Inc. | $118.88 | 1 |
| Janssen Biotech, Inc. | $99.99 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $68.99 | 1 |
| GENZYME CORPORATION | $59.59 | 3 |
| E.R. Squibb & Sons, L.L.C. | $31.56 | 1 |
| Incyte Corporation | $27.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $31.56 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101398923 | CMS |
| GENZYME CORPORATION | $23.38 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139620089 | CMS |
| GENZYME CORPORATION | $16.67 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139620101 | CMS |
| GENZYME CORPORATION | $19.54 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139620149 | CMS |
| Incyte Corporation | $27.20 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141245716 | CMS |
| Janssen Biotech, Inc. | $99.99 | 04/09/2024 | Education | Undisputed | 01/23/2026 | 1078326609 | CMS |
| LEO Pharma Inc. | $118.88 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152630297 | CMS |
| PFIZER INC. | $103.06 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131791537 | CMS |
| PFIZER INC. | $20.11 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130992981 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $68.99 | 07/26/2024 | Education | Undisputed | 01/23/2026 | 1152202219 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.